Bioptik Technology (4161) — Free Cash Flow Generation Index

Latest as of December 2025: 0.91x

Bioptik Technology (4161) has a Free Cash Flow Generation Index of 0.91x as of December 2025. Free cash flow of NT$48.27 Million represents 1% of operating cash flow (NT$53.21 Million). Read Bioptik Technology (4161) total liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.91x
Free Cash Flow / Operating CF

Free Cash Flow

NT$48.27 Million
TWD

Operating Cash Flow

NT$53.21 Million
TWD

Capital Expenditures

NT$4.94 Million
TWD

Bioptik Technology Free Cash Flow Generation Index (2017–2025)

Historical FCF Generation Index trend for Bioptik Technology across 8 annual periods. Explore capital reinvestment ratio of Bioptik Technology to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Bioptik Technology (2017–2025)

Year-by-year Free Cash Flow Generation Index for Bioptik Technology. For the full company profile including market capitalisation, see how much is Bioptik Technology worth.

Year FCG Index Free Cash Flow (TWD) Operating CF Capital Expenditures YoY Change
2025 0.62x NT$37.19 Million NT$59.99 Million NT$22.80 Million ▼ -31.3%
2024 0.90x NT$143.32 Million NT$158.82 Million NT$15.51 Million ▲ +6.3%
2023 0.85x NT$174.91 Million NT$205.95 Million NT$31.04 Million ▲ +23.1%
2022 0.69x NT$37.98 Million NT$55.06 Million NT$17.08 Million ▲ +168.6%
2020 -1.01x NT$-6.61 Million NT$6.57 Million NT$13.18 Million ▼ -429.7%
2019 0.30x NT$12.51 Million NT$41.03 Million NT$27.42 Million ▲ +226.1%
2018 -0.24x NT$-10.11 Million NT$41.83 Million NT$50.96 Million ▲ +94.9%
2017 -4.72x NT$-52.04 Million NT$11.02 Million NT$62.72 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).